Duration of Hospitalization is Associated with the Gut Microbiome in Patients Undergoing Hematopoietic Stem Cell Transplantation: Early Results from a Randomized Trial of Home Versus Hospital Transplantation.

Saved in:
Bibliographic Details
Title: Duration of Hospitalization is Associated with the Gut Microbiome in Patients Undergoing Hematopoietic Stem Cell Transplantation: Early Results from a Randomized Trial of Home Versus Hospital Transplantation.
Authors: Andermann TM; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA., Zeng K; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte Charlotte, North Carolina, USA., Guirales-Medrano S; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte Charlotte, North Carolina, USA.; Bioinformatics and Analytics Research Collaborative, School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA., Groth A; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA., Ramachandran BC; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA., Sun S; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte Charlotte, North Carolina, USA., Sorgen AA; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte Charlotte, North Carolina, USA., Hill L; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, North Carolina, USA., Bush AT; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, North Carolina, USA., Liu H; Bioinformatics and Analytics Research Collaborative, School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA., Jones C; Bioinformatics and Analytics Research Collaborative, School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA.; Department of Biology, University of North Carolina at Chapel Hill, North Carolina, USA., Roach J; Center for Gastrointestinal Biology and Disease (CGIBD), Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, North Carolina, USA., Conlon BP; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, North Carolina, USA., Rao G; Department of Clinical Pharmacy, University of Southern California, California, USA., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, North Carolina, USA., Fodor AA; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte Charlotte, North Carolina, USA., Sung AD; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Kansas, USA.
Source: OBM transplantation [OBM Transplant] 2025; Vol. 9 (3). Date of Electronic Publication: 2025 Aug 25.
Publication Type: Journal Article
Journal Info: Publisher: Lidsen Publishing, Inc Country of Publication: United States NLM ID: 101751093 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2577-5820 (Electronic) Linking ISSN: 25775820 NLM ISO Abbreviation: OBM Transplant Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2577-5820
DOI:10.21926/obm.transplant.2503255